The paper suggests a model for measuring the degree of openness of innovation in firms through the analysis of their annual reports. Two indicators are defined: open innovation generated value, which measures the intensity of outbound processes, and open innovation consumed value, measuring the intensity of inbound ones. The model is applied to a sample of 145 R&D intense companies in the biopharmaceutical industry, defining a positioning map of the firms in six classes.
Measuring Open Innovation in the Bio-Pharmaceutical Industry
MICHELINO, FRANCESCA;LAMBERTI, EMILIA;CAMMARANO, ANTONELLO;CAPUTO, Mauro
2015-01-01
Abstract
The paper suggests a model for measuring the degree of openness of innovation in firms through the analysis of their annual reports. Two indicators are defined: open innovation generated value, which measures the intensity of outbound processes, and open innovation consumed value, measuring the intensity of inbound ones. The model is applied to a sample of 145 R&D intense companies in the biopharmaceutical industry, defining a positioning map of the firms in six classes.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
